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Two-component systems represent the most widely used signaling
paradigm in living organisms. Encoding the prototypical two-
component system in Gram-positive bacteria, the staphylococcal
agr (accessory gene regulator) operon uses a polytopic receptor,
AgrC, activated by an autoinducing peptide (AIP), to coordinate
quorum sensing with the global synthesis of virulence factors. The
agr locus has undergone evolutionary divergence, resulting in the
formation of several distinct inter- and intraspecies specificity
groups, such that most cross-group AIP-receptor interactions are
mutually inhibitory. We have exploited this natural diversity by
constructing and analyzing AgrC chimeras generated by exchange
of intradomain segments between receptors of different agr
groups. Functional chimeras fell into three general classes: recep-
tors with broadened specificity, receptors with tightened specific-
ity, and receptors that lack activation specificity. Testing of these
chimeric receptors against a battery of AIP analogs localized the
primary ligand recognition site to the receptor distal subdomain
and revealed that the AIPs bind primarily to a putative hydrophobic
pocket in the receptor. This binding is mediated by a highly
conserved hydrophobic patch on the AIPs and is an absolute
requirement for interactions in self-activation and cross-inhibition
of the receptors. It is suggested that this recognition scheme
provides the fundamental basis for agr activation and interference.
staphylococci  agr  intradomain chimera  autoinducing peptide
Two-component signaling systems function in the sensing of thecell’s external environment and are probably the most widely
used signaling paradigm in living organisms (1). Many two-
component signaling systems in Gram-positive bacteria use poly-
topic transmembrane receptors that are activated by autoinducing
peptides (AIPs) (2, 3). Although these systems regulate virulence
in staphylococci (agr) (4) and enterococci ( fsr) (5), competence in
bacilli (6) and pneumococci (com) (7), and bacteriocin production
in lactic acid bacteria (pin and ssp) (8, 9), constituting a major
component of the regulatory biology of these organisms, the
mechanism(s) by which peptides bind to and activate the respective
receptors are unknown.
We have found the staphylococcal agr (accessory gene regulator)
system to be particularly amenable to mechanistic investigation in
this context for two reasons: first, because it is conserved through-
out the staphylococci but has undergone a highly significant evo-
lutionary divergence, resulting in four (ormore) different specificity
variants in Staphylococcus aureus and at least 20 others in the
non-aureus species (10–12); and second, because the 7- to 10-aa
AIPs of different staphylococcal species form a close family with a
conserved structure consisting of a 5-aa thiolactone ring (a lactone
ring in one case) and a linear 2- to 5-aa ‘‘tail’’ (13–16). Because the
AIP from any one specificity group generally inhibits agr activation
in the other groups (10, 11, 15, 17, 18), one is providedwith a unique
and powerful set of preexisting tools with which to analyze recep-
tor–ligand interactions, particularly significant biologically because
the predicted mutual exclusion may be the evolutionary driving
force for divergence and speciation in the staphylococci.
In earlier studies, we developed a convenient method for syn-
thesizing the AIPs (13) and constructed a series of group-specific
reporter strains with which to test the activity of these molecules
(19). Using this combination of chemistry and genetics, we have
characterized the four known S. aureus AIPs (20), performed a
detailed structure function analysis of AIP-II (13) (peptides and
receptors are identified by a roman numeral suffix designating their
specificity group), and shown that the interactions between acti-
vating and inhibiting peptides are competitive (14). A fundamental
question raised by these studies is how a wide variety of divergent
peptides can each competitively inhibit the same receptor, whereas
only the single cognate AIP can activate it.
We exploited the natural diversity of the agr system to generate
a series of molecular chimeras in the AgrC receptor domain, whose
behavior might be informative with respect to this question. Seg-
ments of the proximal and distal halves of the polytopic N-terminal
sensor domain were switched among different receptor specificity
types, corresponding to the four known S. aureus agr groups. These
intradomain chimeras were then tested for activation and inhibition
specificity against chemically synthesized native AIPs and a battery
of AIP analogs. This approach localized the region of receptor–
ligand specificity and identified the orientation of the receptor–
ligand interface. Remarkably, however, two of the chimeric recep-
tors could not be inhibited by any AIP tested and had entirely lost
activation specificity (being activated by all but three of the peptides
tested, even those that strongly inhibit all four of the native
receptors). These chimeras allowed us to uncover a key component
of AgrC–AIP recognition, a seemingly promiscuous, hydrophobic
interaction, which may explain the mechanism of staphylococcal
cross-group interference.
Materials and Methods
Bacterial Strains and Growth Conditions. Staphylococcal strains are
derivatives of NCTC8325. Escherichia coli strain JM109 was used
for cloning. RN6734 is our standard laboratory strain and is agr
group I (11). RN7206 is a derivative of RN6734 in which the agr
locus has been replaced by tetM (21). RN4220 is a heavily mu-
tagenized derivative of S. aureus that readily accepts foreign DNA
(22). Overnight cultures of S. aureus on GL media [3 g/liter
casamino acids3 g/liter yeast extract5.9 g/liter NaCl3.3 ml/liter
60% sodium lactate40 ml/liter 25% (vol/vol) glycerol15 g/liter
agar] (23) containing antibiotics when necessary (chloramphenicol,
tetracycline, and erythromycin at 5 or 10 gml) were routinely
used as inocula. S. aureus were grown in CYGP broth (10 g/liter
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casamino acids10 g/liter yeast extract5 g/liter glucose5.9 g/liter
NaCl60 mM glycerophosphate) (23) in the absence of antibiotics
with shaking at 37°C, and cell growth was monitored by a Klett–
Summerson (Klett, Long IslandCity, NY) colorimeter with a green
(540 nm) filter.Media used forE. coliwere Luria broth andLB agar
with ampicillin used for selection at 100 gml.
Construction of Receptor Chimeras. Plasmid pRN7128 served as the
vector for expression of the receptor chimeras inRN7206. pRN7128
is characterized in detail in refs. 14 and 20 but, in brief, carries the
P2::agrCA genes, a P3::blaZ reporter, an ori from pT181 (for
replication in S. aureus), the ermC gene from pE194 (for selection
in S. aureus), and an ampicillinColE1 ori fragment from pUC19
(for replication and selection in E. coli). Plasmid pRN7128 has a
uniqueAflII restriction site at the boundary between the sensor and
signaling domain motifs in agrC. The three other agrC receptors
have been individually cloned to pRN7128 and are characterized in
detail in refs. 14 and 20. Two-step PCR (24) with appropriate
primers and receptor templates was used to construct the chimeric
fusions. The PCR fragments were then ligated back into pRN7128
by using an upstream PstI site and the AflII site. Sequences of the
chimeras were confirmed by dye-terminator DNA sequencing
chemistry (Skirball DNA Sequencing Core Facility). pRN7128
derivatives were electroporated into S. aureus RN4220 (25) and
moved by phage transduction into an agr-null strain, RN7206, to
eliminate the effects of endogenous AIPs on function. The AgrC
receptor histidine kinases (HKs) are referred to in the text as
AgrC-N (N corresponding to the agr specificity group) and the
chimeras are referred to as AgrC-N::C (designating AgrC group N
for the N terminus of the receptor domain and AgrC group C for
the C terminus).
Synthesis of AIPs. All AIPs were chemically synthesized on a
t-butoxycarbonyl-amino acyl-3-mercapto-propionamide-4-methyl-
benzhydrylamine-copoly(styrene-1% DVB) [Boc-AA-(COS)-
MBHA] support and characterized as described in ref. 20. The
3-thiopropionic acid linker on MBHA resin is labile to hydrogen
fluoride (HF)-cleavage conditions, thereby releasing linear thio-
ester peptides upon global deprotection. After removal of HF, the
crude peptide product was precipitated by using cold diethyl ether
(Et2O), washed thoroughly with Et2O, and dissolved in 45%
acetonitrile (CH3CN)50%H2O0.1% trifluoroacetic acid (TFA).
After lyophilization, linear thioester peptides were dissolved again
in CH3CN and H2O with 0.1% TFA and cyclized in solution by the
addition of at least 1 vol of 0.2M phosphate buffer at pH 7. After
cyclization (90%), the peptides were purified by RP-HPLC and
characterized by analytical RP-HPLC, mass spectrometry, amino
acid analysis, and thioester base-lability studies, which collectively
demonstrated that all peptides were of the correct composition and
95%pure. In addition, two-dimensional 1HNMRanalysis yielded
complete assignments for the synthetic peptides. The concentra-
tions of stock solutions were calculated based on amino acid
analysis, with the peptides dissolved in 45% CH3CN55% H2O
0.1% TFA. Peptide stocks were made in 25% propylene glycol50
mM phosphate (pH 5.7) at a known concentration and serially
diluted into the same buffer for assays with cells.
Activation and Inhibition Assays. StrainRN7206 containing the agrC
receptor chimeric fusions were grown with shaking at 37°C in
CYGP to a cell density of 140 Klett (mid-exponential phase) for
assay of -lactamase expression from the P3::blaZ reporter fusion.
Synthetic peptides in 25% propylene glycol0.05 M phosphate (pH
5.7) were added alone (activation) or together (inhibition) at
various concentrations to 96-well plates and incubated with shaking
at 37°C for 60 or 90 min in a ThermoMax microplate reader
(Molecular Devices) with monitoring of cell density at 650 nm.
Assay of -lactamase expression was performed by the nitrocefin
method as described in ref. 4. The data from the -lactamase assay
were normalized to percent maximal activation and plotted as
initial -lactamase reaction velocity versus log peptide concentra-
tion. By using PRISM 3.0 (GraphPad, San Diego), individual agonist
or antagonist concentration–response curves were fitted via non-
linear regression to the following four-parameter Hill equation:
E Basal
Emax Basal
1  10 LogEC50  LogAnH
,
where E denotes effect, [A] denotes the agonist concentration, nH
denotes the midpoint slope, EC50 denotes the midpoint location
parameter, and Emax and Basal denote the upper and lower
Fig. 1. Comparison of the AgrC receptor domains and strategy for subdomain
chimera construction. (A) The domain organization of AgrC. A hydropathy plot
of all known AgrC receptor sequences (residues 1–227) was performed by using
the SEQVU 2.1 program (Garvan Institute of Medical Research, Darlinghurst,
Australia). Yellow shading represents predicted hydrophobic regions, and blue
shading represents hydrophilic regions. Putative transmembrane-spanning do-
mains (TM1–6) were identified by several topological prediction algorithms
(31–35) and are consistent with previous topological (12) and phoA fusion (26)
analyses. A corresponding plot illustrates amino acid sequence identity between
combinations of the four S. aureus AgrC receptors. For each residue, a black bar
represents sequence variation, and a white bar represents sequence identity. The
percentage of sequence identity for each pair in the receptor region (amino acids
1–205) is also denoted. The location of the junction in AgrC used for the con-
struction of the subdomain chimeras is indicated by a dashed line as well as gray
shading in the identity plot and corresponds to the amino acid sequence
Q86I87I88L89Y90C91A92N93, which is identical in AgrCs I, III, and IV. (B) At the top is
adiagramof theagrCA reporter constructwithblaZ transcriptionally fusedtothe
P3 promoter (restriction sites: N, NarI; R, EcoRI; P, PstI; A, AflII; S, SphI). The six
subdomain chimeras for which results are reported are illustrated below. In each
case, the recombinant agrC gene was cloned to the reporter construct replacing
the receptor domain-encoding region of the native gene. Chimeras involving
AgrC-IIwerealsoconstructedbutwereessentially inactiveandarenotpresented.








asymptotes, respectively. For inhibition curves, the midpoint loca-
tion parameter from the above equation reflects the IC50.
Results
Design and Construction of Functional AgrC Chimeras. Because the
receptor has a highly conserved C-terminal cytoplasmic HK do-
main (residues 206–411) and a highly divergent N-terminal poly-
topic transmembrane domain (residues 1–205) (11), it was pre-
dicted and confirmed that the N-terminal domain would be the
sensor and would determine receptor specificity (14, 20). Although
the sensor domains are divergent, their transmembrane topology
appears to be highly conserved, as judged by the spacing of the
putative hydrophobic-helices (Fig. 1A). Thus, it seemed likely that
the exchange of segments within this domain would generate
functional chimeric receptors, whose behaviormight be informative
with respect to the localization of peptide recognition sites, specific
contacts, etc. Accordingly, we have constructed 10 of 12 possible
chimeric derivatives by exchanging the proximal and distal halves of
the sensor domains, using a single conserved motif for all of the
exchanges.
The chimeric AgrC constructs were transduced into an agr-null
S. aureus strain and analyzed for functionality by testing them for
their ability to activate a -lactamase reporter fused to the agr-
RNAIII promoter in response to various AIPs, as diagrammed in
Fig. 1B. Some of the constructs had detectable receptor activity,
whereas others did not; indeed, there was an inverse relationship
between the functionality of the chimera and the degree of se-
quence divergence of the two parental molecules. Thus, the chi-
meras between the two most closely related AgrCs, I and IV (87%
sequence identity), were both functional, those involving AgrC-II,
which is most distant from the others (32% sequence identity) were
not, and those involvingAgrC-III and either I or IV (54% sequence
identity) were functional but had unpredictable activities.
Orientation of the AgrC–AIP Interface.We first examined the activity
of the chimeras between the closely related AgrC-I and AgrC-IV
receptors. The AgrC-I::IV and -IV::I subdomain chimeras were
activated by both AIPs I and IV and inhibited by AIP-II and by a
truncated (‘‘tailless’’) AIP-II variant, with kinetics similar to those
observed with the two native receptors (Table 1 and Fig. 2 A and
B). However, AIP-I was 50- to 100-fold more potent on the
AgrC-IV::I receptor than on the AgrC-I::IV receptor, whereas the
opposite was true for AIP-IV (Table 1), indicating that the major
determinant of AIP recognition is in the distal subdomain of the
sensor, as previously suggested by Lina et al. (26) (see Fig. 1A).
AIPs I and IV differ at only a single residue, D vs. Y at position 5,
within the thiolactone ring (see Fig. 3), indicating that it is the ring
moiety of the AIP that makes the defining group-specific contact
with the distal subdomain. This conclusion was supported by results
with an AIP-IIV variant having asparagine at this position (D5N).
AIP-I D5N activates AgrC-I but, unlike native AIP-I, inhibits
AgrC-IV (20). Revealingly, it has precisely the same effects with the
AgrC-IV::I and -I::IV chimeras, activating the former and inhib-
iting the latter (Fig. 2C andD). However, AgrC-I::IV was activated
by AIP-I much more strongly (EC50 of 1,220 nM) than was the
native AgrC-IV [EC50 of 26,000 nM (20)], suggesting that the
proximal subdomain also contributes a significant role in receptor
function, including specificity. These results suggest that the AIP is
oriented with its ringmoiety facing the distal region of the receptor.
AgrC Chimeras That Show Increased Specificity but Decreased Re-
sponsiveness. The properties of the chimeras involving AgrCs I and
IV and AgrC-III were very much dependent on which subdomain
Table 1. Response of AgrC chimeras to various AIPs
AgrC-I::IV AgrC-III::IV AgrC-IV::I AgrC-III::I AgrC-I::III AgrC-IV::III
Activation (EC50)*
AIP-I  (1,220 nM)   (26 nM)  (1,700 nM)  
AIP-II      (3,100 nM)  (640 nM)
AIP-III      (48 nM)  (4 nM)
AIP-IV  (6 nM)  (340 nM)  (120 nM)   
AIP-I D5N    (440 nM)   
AIP-I D5A      
TrAIP-II‡†     (160 nM)  (50 nM)
AIP-II F9A  
AIP-II L8A  
AIP-II N3A  
LiAIP-I§‡  (3,100 nM)  (6,700 nM)
LiAIP-II   
Inhibition§
AIP-I      
AIP-II      
AIP-III      
AIP-IV      
AIP-I D5N      
AIP-I D5A  
TrAIP-II      
AIP-II F9A 
AIP-II L8A 
AIP-II N3A  
LiAIP-I  
LiAIP-II   
, Activation observed at	200 nM;, activation observed at200 nMinhibition observed;, no activation
at 	10,000 nMno inhibition observed; , AIP is an agonist and was not tested for inhibition.
*Where indicated, EC50 values were obtained as described in Materials and Methods.
†Truncated AIP; contains only the macrocyle without the tail residues.
‡Linear AIP; peptide without the thioester bond.
§In all cases, the most potent agonist for a given chimeric receptor was used for inhibition analysis. IC50 values are
omitted because AIP agonists were used at different concentrations and are thus incomparable. Therefore,
inhibition is only qualitatively scored in this section of the table.
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of AgrC-III was present. In the case of the III::I and III::IV
chimeras activation specificity again followed the distal subdomain:
III::I was activated by AIP-I and III::IV was activated by AIP-IV,
but the AIP concentrations required were 100- to 1,000-fold higher
thanwith the native receptors (Fig. 2E andF).Moreover, there was
no detectable cross-activation byAIPs IVand I on III::I and III::IV,
respectively; on the contrary, AIP-IV cross-inhibited III::I and
AIP-I cross-inhibited III::IV. Both of these chimeras were also
inhibited by AIPs II and III, similarly to the inhibition seen with
native AgrCs I and IV (20). Again, the results support the local-
ization of the AgrC-I and -IV specificity determinants to the distal
subdomain and imply that the proximal subdomain has an impor-
tant role (in this case, greatly diminishing the responsiveness but
increasing the selectivity of the receptor).
AgrC Chimeras That Lack Activation Specificity. The results with the
I::III and IV::III chimeras were, to say the least, surprising. Akin to
the behavior of the chimeras described above, the I::III and IV::III
chimeras were preferentially responsive to AIP-III. However, both
of these chimeras were also strongly activated by otherAIP analogs.
These included AIPs I, II, and IV, which are strong inhibitors of
AgrC-III (13), and AIP-I D5A and truncated AIP-II (trAIP-II),
which are strong inhibitors of all four AgrCs (13, 20). Even linear
AIPs I and II, which are generally inert in this system (11, 16), were
found to activate one or the other of these chimeras, albeit weakly.
Moreover, no AIP or AIP derivative tested could inhibit activation
of either receptor. Consistent with the previous results, it appears
Fig. 3. Sequence, hydrophobicity, and structure of various known and
predicted AIPs. (A) At the top is displayed the sequences and hydrophobicity
profiles of the 24 known or predicted AIPs. Most or all of the staphylococcal
AIPs are 7–10 aa in length. In the alignment, hydrophilic (polar) residues are
colored blue, and hydrophobic residues (nonpolar) are colored yellow. A
shaded box marks the conserved cysteine, which is always 5 aa from the C
terminus, and a black outline traces the conserved hydrophobic macrocycle
residues. N3 in AIP-II and D5 and Y5 in AIP-I and -IV are highlighted because
they are critical for activation (13, 20). Note that AIPs I and IV differ by only this
amino acid and that Staphylococcus intermedius contains a serine in place of
the conserved cysteine. Sequences marked with an asterisk are those that have
been confirmed by in vitro synthesis and mass spectroscopy (11, 13–15, 36) (M.
Kalkum, personal communication). The rest are predicted from the corre-
sponding agrD sequences (12). Because of variation in the N-terminal tail
region, most of the unconfirmed AIPs have been given an arbitrary length of
9 aa. Below this is a schematic model of a generic 9-aa AIP and a magnified
view of the thiolactone bond. As a point of reference, highlighted residues are
identified on the AIP model. (B) A representative dose–response plot with
different AIP-II analogs against the AgrC-IV::III chimera demonstrates the
importance of the conserved hydrophobic macrocycle residues in receptor
recognition. The x axis represents the concentration of AIP, and the y axis
indicates raw -lactamase activity.
Fig. 2. Dose–response curves for various constructs and AIPs. In each case, the
indicated AIP was added in increasing concentrations to an exponential phase
culture containing the indicated reporter. Samples were removed after 1–1.5 h of
incubation at 37°C and assayed for-lactamase activity by the nitrocefin method
as adapted to the microtiter format (11). The y axis for all graphs indicates the
percent maximal activation, and the x axis represents the concentration of the
AIP.A–C,E, andF representdose-dependentactivationof theAgrCchimeraswith
various AIPs. In D are the results of an inhibition test with AIP-I D5N. In this case,
AIP-I or -IV was added at 1,000 nM along with the inhibitor.








that the major specificity determinants reside in the distal domain
of the receptor but the proximal domain influences responsiveness
to noncognate AIPs.
A Conserved Hydrophobic Patch on the AIP Is Required for Activation
and Inhibition. A major implication of these results is that there is
a subtle mismatch between the subdomains in the I::III and IV::III
chimeras that alters the structure of the receptor in such a manner
as to poise it for activation by any ligand that can bind; that is,
activation can occur without any of the putative group-specific
contacts that are presumed to be responsible for activation of the
native receptors. This finding prompted a careful examination of
the AIP sequences. Overall, the AIPs show a gradient of increasing
hydrophobicity from their N to C termini, generally ending with
bulky hydrophobic amino acids at the two C-terminal positions, in
all but one of the 24 known AIP sequences (see Fig. 3) (12). With
the exception of the central cysteine, used for the thiolactone ring,
no other positions in the AIPs are so strongly conserved.
This analysis, coupled with the behavior of the I::III and IV::III
chimeras, suggested that the AIP makes two types of interactions
with the receptor: (i) a hydrophobic type interaction involving one
or both of the C-terminal nonpolar residues in the peptide and (ii)
sequence-specific contacts that result in activation or inhibition,
presumably via change(s) in receptor conformation. According to
this concept, the structural distortion of the I::III and IV::III
chimeras bypasses the need for specific contacts; presumably, all
that is required for activation is the ability to bind. If the two
C-terminal hydrophobic residues are required for this type of
binding, then replacing one or the other or both with a neutral
residue such as alanine is predicted to eliminate binding and thus
to eliminate activation of the I::III and IV::III chimeras.
This prediction was confirmed as shown in Table 1 and Fig. 3B:
The F9A and L8A variants of AIP-II, which had previously been
shown to lack activity with native AgrCs I and II (13), were also
totally inactive toward the I::III and IV::III chimeric receptors. In
contrast, AIPs with alanine replacements at other key sites, AIP-II
N3A andAIP-I D5A, both potent inhibitors of all four of the native
AgrCs, were strong activators of the I::III and IV::III chimeras. This
finding suggests that an alanine replacement at either of the
C-terminal positions in the hydrophobic patch of the AIP causes a
significant defect on receptor binding. Similarly, supernatant pre-
sumably containing the exceptional nativeAIP fromStaphylococcus
cohnii urealyticum containing a C-terminal alanine has no detect-
able inhibitory activity, nor does it activate the I::III or IV::III
chimeras (unpublished results). However, an AIP-II variant with
naphthylalanine at position 9, increasing the hydrophobicity at that
position, had nearly 100-fold reduction in activity with AgrC-II, did
not detectably inhibit AgrC-I (data not shown), and failed to
activate the I::III and IV::III chimeras (Fig. 3B). Thus, the added
bulk of this side chain is not accommodated easily by the native
receptor and not at all by the chimeras, suggesting that steric
constraints may supercede the requirements of the hydrophobic
patch in AIP–AgrC interactions.
Discussion
In this study, we have addressed the processes underlying produc-
tive and interfering communication in the evolutionarily divergent
staphylococcal agr quorum-sensing system. We have been able to
exploit this evolutionary paradigm analytically by testing chemically
synthesized AIP analogs on chimeric AgrC receptors generated by
exchanging regions within the AgrC receptor domain between
receptors of different agr classes. This approach has yielded insight
into the principles of molecular recognition underlying AgrC-AIP
interactions.
Intradomain AgrC Chimeras and Receptor Function. We found that
the functionality of the chimeras depended on the relative
degree of sequence divergence of the two parental molecules.
Thus, intradomain chimeras between closely related AgrCs were
functional (87% to 54% amino acid identity in the receptor
domain), and those between more distantly related AgrCs (32%
amino acid identity) were not functional. These results raised the
question of whether the chimeric receptors were expressed at
equivalent levels and localized properly to the cytoplasmic
membrane. In an attempt to address this question, we prepared
functional N-terminal epitope-tagged versions of the native and
chimeric receptors and also raised polyclonal antisera against the
conserved HK domain, shared between all chimeric derivatives.
However, we have not yet been successful at detecting expression
of either native or chimeric AgrC receptors, even when overex-
pressed from the inducible -lactamase promoter (blaZp). Be-
cause bacterial two-component receptor HKs represent signal
amplifiers (27), they are found in low abundance in the cell
membrane. Thus, the well studied E. coli osmosensor EnvZ has
been shown to be expressed at only
10–100 copies per cell (28),
and similarly low expression levels of AgrC in S. aureus are
almost certainly responsible for our inability to detect even the
native receptors immunologically. However, because the overall
topology, translation-initiation regions, and sizes of the four
receptors are well conserved, it is likely that at least the
functional chimeric receptors were expressed and inserted into
the membrane and that subtle structural features are responsible
for their properties.
The Molecular Basis of AIP–AgrC Recognition in Staphylococcal Quo-
rum Sensing. The following characteristics of AgrC–AIP interac-
tions were determined by our approach. (i) The distal region of the
AgrC receptor domain carries the primary elements involved in
specificity for activation. (ii) Specificity for activation in the AIP, at
least for the very similarAIP-I andAIP-IV, was localized toD5 and
Y5, respectively, in the macrocyclic ring adjacent to the conserved
cysteine. The combination of these two features suggest that the
orientation of the AgrC–AIP interface is between the distal part of
the receptor and the AIP ring moiety. (iii) The proximal domain of
the receptor played a secondary but very revealing role in ligand
cross-reactivity, as it affected receptor responsiveness and in some
cases provided the ability to respond to noncognate AIPs. (iv) A
bulky hydrophobic patch conserved on all staphylococcal AIPs
appears to be a key component of the AgrC–AIP interaction. The
two macrocyclic hydrophobic residues (in the structural context of
the native AIPs), which are clearly insufficient for activation of the
Fig. 4. Hypothetical cartoon model illustrating activation and inhibition of
AgrC. Binding of diverse but structurally similar AIPs to AgrC is driven by the
hydrophobic patch (two circles) in the AIP endocycle region with an undisclosed
hydrophobic binding pocket (shaded in yellow). The sharp features on the AIP
represent specific molecular determinants for activation [N3 in AIP-II and DY5 in
AIP-I and -IV (13, 20)] recognized by he distal subdomain of the receptor (shaded
in blue). Activation is accompanied by molecular rearrangements in the receptor
andor AIP that propagate the signal to activate the HK domain and the subse-
quent phosphorelay to AgrA. Occupancy of a noncognate or inhibitory AIP
lacking the requirements for activation results in competitive inhibition.
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native cognate receptors, may also not be sufficient for cross-
inhibition either. For example, AIP-III is a poor antagonist of
AgrC-I::IV but a strong inhibitor of the native AgrC-I and -IV
receptors, and the lactam analog of AIP-II neither inhibits nor
significantly activates AgrC-II but acts as a potent inhibitor of
AgrC-I, -III, and -IV (13), suggesting that specific contacts or
structural features of the peptide may be involved for inhibition, in
at least some cases, as well as for activation. This finding implies that
inhibition may not be simply a matter of blocking access of the
activating peptide to its site on the receptor but may also require
specific contacts in addition to binding.We also note that one of the
AIPs, that of S. cohnii urealyticum, is predicted to have a C-terminal
alanine, yet supernatant from this strain presumed to contain this
AIP does not inhibit activation of the S. aureus agr groups (unpub-
lished data). It has not yet been determined whether this peptide is
a self-activator; its further study promises to be enlightening with
respect to our model.
A Model for AgrC–AIP Recognition. We propose a simple model for
AgrC–AIP recognition based on the remarkable activities of these
chimeras (Fig. 4). Driven by the bulky hydrophobic amino acids in
themacrocycle, any AIP can be accommodated into a promiscuous
binding pocket within the receptor.We note that the EC50 and IC50
values for activation and inhibition are comparable (14, 20), sug-
gesting that the binding energy for either is approximately the same.
It is therefore suggested that both cognate and heterologous AIPs
bind competitively and with equal strength to the receptor. The
conserved hydrophobic patch in the macrocycle interacts with an
as-yet-unidentified hydrophobic pocket that might be comprised of
both the proximal and distal moieties of theAgrC receptor domain.
Further analysis on this feature may be complicated by the fact that
the receptor is also likely to exist as a preformed dimer as
demonstrated for other two-component receptor HKs and methyl-
accepting chemotaxis proteins (MCPs) (29, 30). A dimer with two
(or more) AIP binding sites could also account for the previously
observed cooperativity of the agr response both for activation and
inhibition (13, 14, 20). Ligand binding is likely accompanied by
conformational changes in the AIP andor the receptor for acti-
vation and, perhaps, for inhibition, but it is not known what these
changes may comprise or where they may occur. Clearly, these
features will need to be addressed in future studies bymore rigorous
analysis.
A Potential Role for AgrC Chimeras in the Discovery of Quorum-
Sensing Inhibitors. Although our understanding of the significance
of quorum-sensing competition on the biology of staphylococci has
remained elusive, this characteristic inhibitory effect has shown
therapeutic potential: A single dose of anAIP antagonist blocks the
formation of an experimental murine abscess (13), and we expect
that fuller understanding of the AIP–AgrC interaction will enable
the design of more potent inhibitors. The properties of the chimeric
receptors analyzed in this studymay significantly aid in this strategic
approach by serving in a gain-of-function (activation) rather than a
loss-of-function (inhibition) screen of the agr response. For exam-
ple, compounds that activate the highly promiscuous AgrC-IV::III
chimera, which would be readily identifiable in a high-throughput
screen, may represent potent inhibitors of the native receptors.
Accommodation of Diverse Ligands Provides the Fundamental Basis
for Quorum-Sensing Interference andMay Drive the Generation of agr
Diversity.Afundamental conclusion from thiswork is thatAgrChas
the intrinsic ability to recognize any structurally appropriate ligand,
and that cognate AIP–AgrC interactions may be a consequence of
conformational specificity rather than rigid allele-specificity. If
receptor activation were dependent on highly allele-specific AIP–
AgrC interactions, we probably would have been unsuccessful at
generating functional chimeric receptors by wholesale exchange of
receptor subdomains, because residues required for activation in
both the receptor and the AIP would have likely been mismatched.
Instead, we created chimeras from receptors sharing only 54%
sequence identity that were activated in response to various AIPs,
indicating that the hallmark ofAgrC–AIP recognition for activation
may not be allele-specific but dependent on subtle conformational
variations.
We propose that accommodation of diverse ligands by the
receptor is a prerequisite for the evolution of cognate recognition
and may provide the mechanism for interference by noncognate
AIPs. Coevolution of agrC and agrDmay be triggered by mutations
in one component that reduce or eliminate AgrC–AIP activity but
do not abolish binding, so that activity could then be restored by a
compensatory mutation(s) in the other component. Hence, main-
tenance of theAgrC–AIP interactionwould be vital to evolutionary
divergence, and mutations that eliminate AgrC–AIP binding alto-
gether would presumably represent evolutionary dead-ends. We
suggest that an accommodating AIP-binding pocket may serve as
a molecular scaffold for the preservation of this interaction. This
defining characteristic would permit the evolution of agr diversity
and provide a mechanism for AgrC–AIP competitive inhibition
and, perhaps, biological isolation.
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